Abbott Laboratories (ABT) FCF Payout Ratio Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.40% |
| Dec 31, 2025 | 13.80% |
| Sep 30, 2025 | 2.03% |
| Jun 30, 2025 | -6.74% |
| Mar 31, 2025 | -9.36% |
| Dec 31, 2024 | 9.25% |
| Sep 30, 2024 | 3.96% |
| Jun 30, 2024 | -6.83% |
| Mar 31, 2024 | 0.37% |
| Dec 31, 2023 | 0.40% |
| Sep 30, 2023 | 20.08% |
| Jun 30, 2023 | 19.62% |
| Mar 31, 2023 | 14.63% |
| Dec 31, 2022 | 6.01% |
| Sep 30, 2022 | 6.09% |
| Jun 30, 2022 | -0.67% |
| Mar 31, 2022 | -20.72% |
| Dec 31, 2021 | -6.43% |
| Sep 30, 2021 | -3.36% |
| Jun 30, 2021 | -4.19% |
| Mar 31, 2021 | 18.25% |
| Dec 31, 2020 | -19.83% |
| Sep 30, 2020 | -2.33% |
| Jun 30, 2020 | 13.71% |
| Mar 31, 2020 | 25.80% |
| Dec 31, 2019 | -4.04% |
| Sep 30, 2019 | 0.53% |
| Jun 30, 2019 | 13.09% |
| Mar 31, 2019 | -18.76% |
| Dec 31, 2018 | 18.26% |
| Sep 30, 2018 | -21.36% |
| Jun 30, 2018 | 0.22% |
| Mar 31, 2018 | -13.32% |
| Dec 31, 2017 | -13.20% |
| Sep 30, 2017 | -0.28% |
| Jun 30, 2017 | -3.03% |
| Mar 31, 2017 | 28.89% |
| Dec 31, 2016 | -7.43% |
| Sep 30, 2016 | 8.00% |
| Jun 30, 2016 | 10.49% |
| Mar 31, 2016 | -36.35% |
| Dec 31, 2015 | 12.68% |
| Sep 30, 2015 | 9.57% |
| Jun 30, 2015 | 8.69% |
| Mar 31, 2015 | -39.14% |
| Dec 31, 2014 | -2.01% |
| Sep 30, 2014 | 9.37% |